This week’s UK tech funding deals include record-breaking quantum computing group Oxford Quantum Circuits, Newcastle spinout Gnosis Health and more.
UKTN tracked £480.1m worth of UK tech investment this week (1 June to 5 June), a 367% week-on-week increase across 12 funding rounds.
Here’s your weekly roundup of UK tech startup funding deals.
Oxford Quantum Circuits – £260m
Sector: Quantum Computing
HQ: Reading
Round: Series C
Investors: Bullhound Capital, British Business Bank, Fynveur, COFIDES, Alpha Edison, Fulcrum Asset Management, Pentland Ventures, Magdalen College Oxford, Adaptive Capital Partners, Firgun Ventures, 18 West, Oxford Capital, Oxford Science Enterprises, SBI, Chevron Technology Ventures, The University of Tokyo Edge Capital Partners Co. and OTIF Ventures
Founded in 2017, Oxford Quantum Circuits develops and operates superconducting quantum computers designed for deployment in data-centre environments serving enterprise and government customers.
Wordsmith AI – £52.1m
Sector: Legal tech
HQ: Edinburgh
Round: Series B
Investors: Highland Europe and Index Ventures
Founded in 2023, Wordsmith AI builds an AI platform for in-house legal teams designed to capture, triage, resolve, and record business legal requests in a centralised workspace.
IMU Biosciences – £40m
Sector: Biotech
HQ: London
Round: Series A
Investors: IQ Capital, Molten Ventures, British Business Bank and Meltwind
Founded in 2021, IMU Biosciences combines multi-omic analysis with machine learning to decode the human immune system from blood samples, creating clinical-scale universal standards for immune profiling.
Semble – £30m
Sector: Health tech
HQ: London
Round: Series C
Investors: Revaia, Partech, Mercia Ventures and Octopus Ventures
Founded in 2018, Semble provides an integrated outpatient practice management platform that acts as an AI orchestration layer connecting the entire clinical and patient care journey.
Apoha – £26.7m
Sector: DeepTech / AI
HQ: London
Round: Series A
Investors: Singular, Draper Associates, Redalpine, Seedcamp, Wilbe, Nucleus and Innovate UK
Founded in 2022, Apoha develops a data layer called “liquid state intelligence” designed to help physical-world AI systems perceive and predict how matter, formulations, and molecules behave.
Geordie AI – £22.3m
Sector: Cybersecurity
HQ: London
Round: Series A
Investors: Balderton
Founded in 2025, Geordie AI builds a real-time security and governance platform that gives enterprises visibility, control, and behavioural constraints over their deployed AI agent networks.
Gigaton – £19.3m
Sector: CleanTech / AI
HQ: London
Round: Series A
Investors: Plural, 2150, Semapa Next, Planet A Ventures, Cambridge Enterprise Ventures, UCL Technology Fund and Clean Growth Fund
Founded in 2023, Gigaton creates autonomous, self-learning AI control software built to simulate, adjust, and optimise complex industrial processes for energy-intensive manufacturing plants.
Airspeed – £14.9m
Sector: AI
HQ: London
Round: Series A
Investors: DN Capital, Vi Partners, Framework Venture Partners and Atlassian Ventures
Founded in 2022, Airspeed (formerly Glyphic) develops an agent-native go-to-market execution layer that utilises autonomous AI agents to turn customer conversations and commercial data into CRM workflows.
Flok Health – £9.5m
Sector: Health tech
HQ: London
Round: Series A
Investors: Albion VC, Eka VC, Form Ventures and Mercia Ventures
Founded in 2022, Flok Health operates an AI-driven digital physiotherapy clinic that uses video manipulation technology to deliver completely autonomous healthcare pathways for musculoskeletal conditions.
Laverock Therapeutics – £2.2m
Sector: Health tech
HQ: London / Stevenage
Round: Grant
Investors: Innovate UK
Founded in 2021, Laverock Therapeutics utilises programmable, disease-responsive gene-control technology to engineer advanced targeted cell therapies for oncology and non-oncology indications.
Lune & Wild – £2m
Sector: Foodtech
HQ: London
Round: Series A
Investors: Guinness Ventures and angels
Founded in 2021, Lune & Wild produces premium, organic, chef-crafted meals and snacks specifically tailored for babies and young children to support paediatric nutrition.
Gnosis Health – £1.1m
Sector: Health tech
HQ: Newcastle
Round: Seed
Investors: Innovate UK, SFC Capital and Northstar Ventures
Founded in 2023, Gnosis Health (a university spinout) develops “MAXine,” an AI-powered digital healthcare assistant that integrates wearable and behavioural data to provide remote, adaptive monitoring for Parkinson’s disease.
